Last month, pharmacists across the US found a pleasant surprise when they discovered that the vials of Pfizer's COVID-19 vaccine contained extra doses.
As a result, Pfizer will now ship fewer vials of vaccine to the US to account for that, according to a New York Times report. The pharmaceutical company has committed to providing 200 million vaccine doses to the US by the end of July. The extra doses found in the initial allocations will now count toward that number.
Pfizer charges by the dose and for weeks has reportedly pushed officials at the US Food and Drug Administration to formally acknowledge that the vials contain six (and sometimes seven) doses, instead of five.
Earlier this month, the FDA obliged, changing the wording of the vaccine's emergency use authorization, according to The Times. Pfizer officials argued the distinction was necessary, since the federal government's contract required payment by the dose.